1 |
Acetylcysteine
| 3件: ACETYLCYSTEINE ACETYLCYSTEINE; Mucomyst; N-Acetylcysteine | 1件: D00221
D00221
| - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
2 |
Ammonia
| 1件: Ammonia Ammonia | 1件: D02916
D02916
| - | - | 2件: 6 6, 296 |
3 |
Belimumab
| 2件: Belimumab Belimumab; BENLYSTA | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 |
4 |
Bezafibrate
| 1件: Bezafibrate Bezafibrate | 1件: D01366
D01366
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 7件: 20 20, 93, 94, 160, 296, 316, 324 |
5 |
Cefoperazone
| 1件: Cefoperazone Cefoperazone | 1件: D07645
D07645
| - | - | 1件: 296 296 |
6 |
Chloride ion
| 1件: Chloride Chloride | - | - | - | 28件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 |
7 |
Cysteine
| 2件: Cysteine Cysteine; Cysteine hydrochloride | - | - | - | 10件: 13 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 |
8 |
Desflurane
| 1件: Desflurane Desflurane | 1件: D00546
D00546
| - | - | 2件: 22 22, 296 |
9 |
Dexamethasone
| 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
10 |
Dimethyl fumarate
| 3件: Dimethyl fumarate Dimethyl fumarate; Dimethylfumarat; TECFIDERA | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 5件: 13 13, 49, 51, 86, 296 |
11 |
Filgrastim
| 7件: Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; Neupogen; TEVAGRASTIM; Zarzio | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 35件: 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
12 |
Folic acid
| 5件: Acide folique Acide folique; Folate; Folic acid; Multivitamin; NICOTINAMIDE | 1件: D00070
D00070
| - | - | 6件: 6 6, 41, 46, 49, 84, 296 |
13 |
Gold
| 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 |
14 |
Icosapent
| 2件: Eicosapentaenoic Acid Eicosapentaenoic Acid; Icosapent | 1件: D08061
D08061
| - | - | 11件: 8 8, 46, 48, 49, 96, 97, 113, 296, 297, 301, 338 |
15 |
Icosapent ethyl
| 2件: Ethyl-EPA Ethyl-EPA; Icosapent | 1件: D01892
D01892
| - | - | 2件: 8 8, 296 |
16 |
Indocyanine green
| 1件: Indocyanine Green Indocyanine Green | 1件: D01342
D01342
| - | - | 8件: 22 22, 46, 51, 96, 235, 278, 291, 296 |
17 |
Lactobacillus casei
| 2件: Fusion Fusion; Lactobacillus casei | 1件: D04351
D04351
| - | - | 10件: 6 6, 11, 13, 46, 49, 69, 70, 97, 271, 296 |
18 |
Magnesium
| 1件: Magnesium Magnesium | - | - | - | 19件: 6 6, 11, 13, 46, 51, 63, 64, 70, 93, 97, 111, 166, 225, 235, 284, 291, 296, 297, 298 |
19 |
Magnesium gluconate
| 2件: Magnesium Magnesium; Magnesium gluconate | 1件: D04835
D04835
| - | - | 2件: 296 296, 297 |
20 |
Magnesium sulfate
| 1件: Magnesium sulfate Magnesium sulfate | 1件: D01108
D01108
| - | - | 3件: 11 11, 296, 297 |
21 |
Maralixibat
| 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 3件: 296 296, 297, 338 |
22 |
Medium-chain triglycerides
| 3件: Medium chain triglyceride Medium chain triglyceride; Smofkabiven; SMOFLipid | - | - | - | 5件: 6 6, 66, 96, 296, 318 |
23 |
Meloxicam
| 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 46 46, 49, 271, 296 |
24 |
Methylprednisolone
| 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
25 |
Neomycin
| 1件: Neomycin Neomycin | 1件: D08260
D08260
| - | - | 3件: 96 96, 97, 296 |
26 |
Norepinephrine
| 2件: Norepinephrine Norepinephrine; Norepinephrine Bitartrate | 1件: D00076
D00076
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 22 22, 296 |
27 |
Obeticholic acid
| 4件: 6-ECDCA 6-ECDCA; 6-ethylchenodeoxycholic acid; OBETICHOLIC ACID; Ocaliva | 1件: D09360
D09360
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 3件: 93 93, 265, 296 |
28 |
Odevixibat
| 1件: Odevixibat Odevixibat | 1件: D11716
D11716
| 1件: SLC10A2 SLC10A2 💬 | 1件: Bile secretion Bile secretion 💬 | 3件: 296 296, 297, 338 |
29 |
Pentoxifylline
| 1件: Pentoxifylline Pentoxifylline | 1件: D00501
D00501
| - | - | 12件: 26 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 |
30 |
Prednisolone
| 3件: Prednisolona Prednisolona; PREDNISOLONE; Prednisolonum | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
31 |
Propofol
| 2件: PROPOFOL PROPOFOL; Propofol Injection | 1件: D00549
D00549
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 9件: 6 6, 21, 22, 34, 46, 70, 75, 98, 296 |
32 |
Propranolol
| 2件: Propanolol Propanolol; Propranolol | 1件: D08443
D08443
| 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 158, 167, 227, 278, 296 |
33 |
Rifaximin
| 3件: Rifaximin Rifaximin; RIFAXIMINA; Xifaxan | 1件: D02554
D02554
| - | - | 9件: 6 6, 65, 93, 94, 96, 97, 99, 296, 299 |
34 |
Rituximab
| 6件: MABTHERA MABTHERA; Rituxan; RITUXIMAB; Rixathon; Ruxience; TRUXIMA | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
35 |
Rocuronium
| 2件: Rocuronium Rocuronium; Rocuronium Bromide | - | - | - | 2件: 70 70, 296 |
36 |
Sevoflurane
| 1件: Sevoflurane Sevoflurane | 1件: D00547
D00547
| - | - | 7件: 6 6, 21, 22, 34, 98, 225, 296 |
37 |
Sulfate ion
| 1件: Sulfate Sulfate | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 |
38 |
Ursodeoxycholic acid
| 4件: UDCA UDCA; Ursodeoxycholic acid; Ursodiol; Ursofalk | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 14件: 6 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 |
39 |
Vancomycin
| 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 |